STOCK TITAN

GRAIL, Inc. Form 4 Filings

GRAL NASDAQ

Every Form 4 that GRAIL, Inc. (GRAL) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow GRAL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GRAL filings page.

Rhea-AI Summary

GRAIL, Inc. (GRAL) reported that Chief Executive Officer and director Joshua J. Ofman sold 5,000 shares of Common Stock on August 27, 2026 in an open-market or private transaction pursuant to a Rule 10b5-1 trading plan. The weighted average sale price was $85.0196 per share, with individual trades between $85.00 and $85.11. Following this sale, Ofman directly holds 397,271 shares of GRAIL common stock.

Rhea-AI Summary

GRAIL, Inc. (GRAL) Chief Financial Officer Aaron Freidin reported selling 7,900 shares of common stock on August 27, 2026 in an open-market transaction under a Rule 10b5-1 trading plan. The weighted average sale price was $85.01 per share, with individual trades between $85.00 and $85.11. After this sale, Freidin directly holds 253,083 shares, which include 314 shares acquired through the company’s ESPP on May 14, 2026.

Rhea-AI Summary

CHASE WILLIAM J reported acquisition or exercise transactions in this Form 4 filing.

GRAIL, Inc. director William J. Chase received a grant of 276 deferred stock units on July 15, 2026 under the deferred stock program and 2024 Equity Incentive Plan, in lieu of $20,568.49 of cash director fees, priced at $74.36 per share and vesting immediately, bringing his direct holdings to 42,978 shares.

Rhea-AI Summary

SUMME GREGORY L reported acquisition or exercise transactions in this Form 4 filing.

GRAIL, Inc. director Gregory L. Summe received a grant of 427 deferred stock units under the company’s deferred stock program and 2024 Equity Incentive Plan in lieu of $31,787.67 of cash director fees, valued at $74.36 per unit and vesting immediately, bringing his directly reported holdings to 45,672 shares.

Rhea-AI Summary

MIZELL STEVEN reported acquisition or exercise transactions in this Form 4 filing.

Steven Mizell, a director of GRAIL, Inc., received a grant of 268 deferred stock units as part of his director compensation. The award is valued at $74.36 per unit, or $19,945.21 in lieu of cash fees, and vests immediately. After this grant, he directly holds 42,830 shares of common stock.

Rhea-AI Summary

CHASE WILLIAM J reported acquisition or exercise transactions in this Form 4 filing.

GRAIL, Inc. director William J. Chase received an equity award of 5,491 deferred stock units (DSUs) under the company’s 2024 Equity Incentive Plan. Each DSU represents the right to receive one share of common stock upon settlement.

The DSUs vest in full on the earlier of June 18, 2027 or the date of the next annual meeting of stockholders, subject to Chase’s continued service through the vesting date. Following this award, Chase directly holds 42,702 shares of GRAIL common stock.

Rhea-AI Summary

GRAIL, Inc. director Steven Mizell received an equity award of 5,491 deferred stock units (DSUs) under the company’s 2024 Equity Incentive Plan, in lieu of 5,491 restricted stock units. The DSUs vest in full on June 18, 2027 or on the date of the next annual stockholder meeting, subject to continued service, and will settle into an equal number of common shares. After this grant, Mizell directly holds 42,562 shares. This is a compensation-related, non‑market acquisition rather than an open‑market share purchase.

Rhea-AI Summary

SUMME GREGORY L reported acquisition or exercise transactions in this Form 4 filing.

GRAIL, Inc. director Gregory L. Summe received an equity award of 5,491 deferred stock units under the company’s 2024 Equity Incentive Plan. Each unit represents one share of common stock to be delivered at settlement.

The DSUs vest in full on the earlier of June 18, 2027 or the next annual stockholder meeting, subject to his continued service. After this grant, Summe directly holds 45,245 shares of GRAIL common stock.

Rhea-AI Summary

Krevans Sarah reported acquisition or exercise transactions in this Form 4 filing.

GRAIL, Inc. reported that director Sarah Krevans received an equity award of 5,491 deferred stock units (DSUs) under the company’s 2024 Equity Incentive Plan. The DSUs vest in full on the earlier of June 18, 2027 or the next annual stockholder meeting, subject to continued service. Each DSU will settle into one share of common stock, and following this grant she holds 42,628 common shares directly.

Rhea-AI Summary

GRAIL, Inc.'s Chief Growth Officer Andrew John Partridge reported an automatic sale of common stock tied to equity compensation. On the transaction date, an executing broker sold 1,491 shares in open-market trades at a weighted average price of $61.08 per share to cover withholding taxes when an award vested and shares were delivered. After these sell-to-cover transactions, Partridge directly held 163,738 shares of GRAIL common stock, indicating this was a small, tax-related disposition relative to his remaining stake.

Rhea-AI Summary

Ofman Joshua J. reported acquisition or exercise transactions in this Form 4 filing.

GRAIL, Inc. director and Chief Executive Officer Joshua J. Ofman received equity compensation in the form of common‑stock–settled restricted stock units. He was granted 27,901 shares and 3,154 shares of common stock-equivalent awards, not purchased on the open market. These RSUs vest in four substantially equal annual installments beginning on May 31, 2027, contingent on continued service, and will be settled in common stock upon vesting. Following these awards, he directly holds 402,271 shares of GRAIL common stock.

Rhea-AI Summary

GRAIL, Inc. director Steven Mizell received an equity-based compensation award instead of cash fees. He was granted 396 deferred stock units of common stock under the company’s deferred stock program and 2024 Incentive Award Plan, in lieu of $19,726.03 of director cash fees, based on a price of $49.79 per share, which was the closing price on April 15, 2026. The award vests immediately on the grant date, and following this grant he directly holds 37,071 shares of common stock. This transaction reflects a non-open-market grant/award acquisition rather than a market purchase.

Rhea-AI Summary

CHASE WILLIAM J reported acquisition or exercise transactions in this Form 4 filing.

GRAIL, Inc. director William J. Chase received a grant of 408 shares of common stock in the form of deferred stock units. The award was issued under the company’s deferred stock program and 2024 Incentive Award Plan in lieu of $20,342.47 of cash director fees.

The grant was valued at $49.79 per share, equal to the closing price of GRAIL’s common stock on April 15, 2026, and vests immediately on the grant date. After this compensation-related award, Chase directly holds 37,211 shares of GRAIL common stock.

Rhea-AI Summary

GRAIL, Inc. director Gregory L. Summe received an equity-based compensation award rather than cash fees. He acquired 631 deferred stock units valued at $49.79 per share, in lieu of $31,438.36 of director fees, under the company’s deferred stock program and 2024 Incentive Award Plan. The units vest immediately on the grant date, and following this grant he holds 39,754 shares of common stock directly.

Rhea-AI Summary

GRAIL, Inc.’s Chief Financial Officer, Aaron Freidin, reported an automatic sale of 45,806 shares of common stock at a weighted average price of $49.9176 per share. According to the footnote, these were broker-executed “sell-to-cover” transactions to pay withholding taxes upon award vesting and share delivery. After these sales, Freidin directly holds 260,669 shares of GRAIL common stock.

Rhea-AI Summary

GRAIL, Inc. director and Chief Executive Officer Robert P. Ragusa reported an automatic tax-related share sale. On the transaction date, an executing broker sold 123,502 shares of Common Stock in a sell-to-cover transaction to satisfy withholding taxes tied to award vesting and share delivery.

The broker executed the sales as part of a block trade at a weighted average price of $49.9176 per share. After these transactions, Ragusa directly holds 518,582 shares of GRAIL common stock, indicating he retains a substantial equity position despite the tax-driven sale.

Rhea-AI Summary

GRAIL, Inc. President and director Joshua J. Ofman reported an automatic sale of common stock tied to tax withholding. An executing broker sold 61,665 shares in a sell-to-cover transaction following award vesting at a weighted average price of $49.9176 per share. After these sales, Ofman directly holds 371,216 shares of GRAIL common stock. The footnote explains the shares were sold to cover withholding taxes and executed as part of a block trade across multiple transactions.

Rhea-AI Summary

GRAIL, Inc.'s Chief Financial Officer, Aaron Freidin, reported automatic tax-related stock sales. On March 5 and March 9, he sold a total of 3,147 shares of GRAIL common stock in open-market transactions ranging from $46.74 to $53.01 per share.

According to the disclosure, these were automatic "sell-to-cover" trades executed by a broker to cover withholding taxes when equity awards vested and shares were delivered, rather than discretionary portfolio sales. After these transactions, Freidin directly owned 306,475 shares of GRAIL common stock.

Rhea-AI Summary

GRAIL, Inc. President Joshua J. Ofman reported automatic sales of 3,627 shares of common stock to cover taxes on vested awards. According to the filing, an executing broker sold shares in block trades on March 5 and March 9, 2026 at weighted average prices of $53.01, $47.93, and $46.74 per share. After these sell-to-cover transactions, Ofman directly owned 432,881 shares of GRAIL common stock.

Rhea-AI Summary

GRAIL, Inc. director and Chief Executive Officer Robert P. Ragusa reported sales of a total of 8,441 shares of common stock in open-market transactions. The sales occurred on March 5 and March 9, 2026 at prices ranging from $46.73 to $53.01 per share.

According to the footnote, these were automatic “sell-to-cover” trades executed by a broker to cover withholding taxes upon award vesting and share delivery, and the reported prices are weighted averages for multiple trades. After these transactions, Ragusa directly holds 642,084 shares of GRAIL common stock.

Rhea-AI Summary

GRAIL, Inc. president Joshua J. Ofman reported a mix of equity awards and tax-related share sales. He received an award of 84,540 restricted stock units, which will vest in four substantially equal annual installments beginning on February 28, 2027, with each unit settling into one share of common stock upon vesting.

On March 2, 2026, an executing broker sold a total of 17,002 shares of common stock in automatic “sell-to-cover” transactions to satisfy withholding taxes upon award vesting, at weighted average prices of $51.7509 and $50.0853 per share. After these sales, Ofman directly owned 436,508 shares of common stock. His reported holdings were also adjusted to include 152 additional dividend shares received in connection with the GRAIL spin-off from Illumina.

Rhea-AI Summary

GRAIL, Inc. reported that Chief Financial Officer Aaron Freidin received an award of 60,118 restricted stock units on February 27, 2026. These RSUs will vest in four substantially equal annual installments beginning on February 28, 2027, and each unit will settle into one share of common stock when vested.

On March 2, 2026, an executing broker carried out automatic sell-to-cover transactions totaling 9,573 shares of common stock at weighted average prices of $50.0853 and $51.8611 to cover withholding taxes tied to award vesting and share delivery. After these transactions, Freidin directly held 309,622 shares of GRAIL common stock.

Rhea-AI Summary

GRAIL, Inc. director and Chief Executive Officer Robert P. Ragusa reported two automatic sell-to-cover transactions of common stock tied to equity award vesting. He disposed of 35,787 shares at an average price of $50.0853 and 1,717 shares at $51.8430 to cover withholding taxes.

After these tax-related sales, he continued to hold 650,525 shares of GRAIL common stock directly. The prices reported represent weighted average prices calculated by the executing broker for block trades executed in multiple transactions.

Rhea-AI Summary

GRAIL, Inc. director William J. Chase received an equity grant for his board service. On January 15, 2026, he was granted 213 deferred stock units of GRAIL common stock at a price of $97.44 per share, in lieu of $20,794.52 of cash fees otherwise payable for his role as a director.

These awards vest immediately on the grant date, meaning the units are fully earned right away. Following this transaction, Chase beneficially owned 36,803 shares of GRAIL common stock in direct form.

Rhea-AI Summary

GRAIL, Inc. director Gregory L. Summe received equity compensation instead of cash fees. On January 15, 2026, he was granted 329 deferred stock units of GRAIL common stock, recorded at a price of $97.44 per share, in lieu of $32,136.98 in cash director fees. These awards vest immediately on the grant date and increase his directly held beneficial position to 39,123 shares of common stock. This filing reflects routine director compensation paid in stock units rather than cash.

Rhea-AI Summary

GRAIL director Steven Mizell received 206 deferred stock units of common stock on January 15, 2026 as director compensation. These units were granted under the company’s deferred stock program and 2024 Incentive Award Plan in lieu of $20,164.38 of cash fees for his board service, using a price of $97.44 per share, which matched the closing market price on the grant date. The awards vest immediately upon grant, meaning they are fully earned right away. Following this grant, Mizell directly beneficially owns 36,675 shares of GRAIL common stock.

Rhea-AI Summary

GRAIL, Inc.'s Chief Financial Officer reported an insider sale of company stock. On 12/03/2025, the reporting person sold 25,000 shares of GRAIL common stock in an open market transaction coded "S" (sale). The weighted average sale price was $99.1527 per share, with individual trades executed between $99.00 and $99.76.

After this transaction, the reporting person beneficially owned 259,077 shares of GRAIL common stock, held directly. The footnote explains that the reported price is an average across multiple trades and that detailed trade-level pricing information within the stated range is available upon request.

Rhea-AI Summary

GRAIL, Inc. (GRAL) reported an insider tax-related stock sale by its Chief Financial Officer. On 11/17/2025, the CFO disposed of 1,697 shares of common stock in an automatic sell-to-cover transaction at a weighted average price of $79.2 per share. These sales were executed by a broker to cover withholding taxes due upon the vesting and delivery of an equity award, rather than as a discretionary open-market sale.

After this transaction and a small correction of 10 shares to fix a prior reporting error, the reporting person beneficially owns 284,077 shares of GRAIL common stock, including 641 shares acquired through the company’s employee stock purchase plan on November 14, 2025.

Rhea-AI Summary

GRAIL, Inc. (GRAL) disclosed a routine director equity grant. On October 15, 2025, director William Chase received 275 deferred stock units in lieu of $20,794.52 of cash director fees, valued at $75.52 per share, the closing price that day. The awards vest immediately upon grant. After the transaction, his beneficial ownership was 36,590 shares, held directly.

Rhea-AI Summary

GRAIL, Inc. (GRAL) reported an insider transaction on a Form 4. CEO and director Robert Ragusa executed an automatic sell-to-cover of 7,239 shares of common stock on 10/15/2025 at a weighted average price of $68.88 to cover withholding taxes upon award vesting and share delivery.

After the transaction, Ragusa beneficially owned 727,388 shares, held directly. The sale was reported under transaction code “S” and occurred as part of a block trade executed in multiple transactions.

Rhea-AI Summary

GRAIL, Inc. (GRAL) reported a director equity grant on Form 4. On October 15, 2025, director Gregory Summe received 425 deferred stock units under the company’s deferred stock program and 2024 Equity Incentive Plan in lieu of $32,136.99 of cash director fees, based on the $75.52 closing price of the company’s common stock on the grant date. The awards vest immediately.

Following this transaction, Mr. Summe beneficially owned 38,794 shares, held directly.

Rhea-AI Summary

GRAIL, Inc. (GRAL) reported a director equity grant. On 10/15/2025, Director Steven Mizell acquired 267 deferred stock units under the company’s deferred stock program and 2024 Equity Incentive Plan. The grant was issued in lieu of $20,164.38 of cash fees, using a price per share of $75.52 (the closing price on the grant date). The awards vest immediately upon grant. Following this transaction, the director beneficially owned 36,469 shares, held directly.

Rhea-AI Summary

GRAIL, Inc. (GRAL) reported insider stock sales by President Joshua Ofman on a Form 4. On 10/15/2025, he sold 8,865 shares of common stock at an average price of $76.0276. On 10/16/2025, he sold 6,114 shares at an average price of $82.01.

Following these transactions, Ofman beneficially owns 381,818 shares directly. The filing notes the sales were made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2025.

Rhea-AI Summary

Insider sale reported for GRAIL, Inc. (GRAL). The reporting person, Joshua J. Ofman (an officer listed as President), sold 81,385 shares of GRAIL common stock on 10/06/2025 in transactions executed as a block trade at a weighted average price of $62.5 per share. After the reported sale, Mr. Ofman beneficially owned 396,797 shares. The Form 4 was signed by an attorney-in-fact on 10/08/2025. The filer states the reported price is a broker-calculated weighted average for multiple sell-to-cover transactions and offers to provide detailed per-trade pricing on request.

Rhea-AI Summary

Joshua J. Ofman, President of GRAIL, Inc. (GRAL), reported a sale of 9,692 shares of common stock on 10/02/2025 at a reported price of $64.0025 per share. After the transaction he beneficially owns 478,182 shares. The filing notes the sale was executed under a Rule 10b5-1 trading plan adopted on March 13, 2025, and the Form 4 was signed by an attorney-in-fact on 10/03/2025. The report is a routine Section 16 disclosure showing an officer-initiated disposition under an established trading plan.